Evidence map›Paper›PMID 36346913›Full record

ArticleBioconjugate chemistry2022

A Universal and Modular Scaffold for Heparanase Activatable Probes and Drugs.

Kelton A Schleyer, Jun Liu, Zixin Chen, Zhishen Wang, Yuzhao Zhang, Junxiang Zuo, Alberto Jimenez Ybargollin, Hua Guo, Lina Cui

Open access · greenAbstract read
In one paragraph

Article in Bioconjugate chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kelton A SchleyerDepartment of Medicinal Chemistry, College of Pharmacy, UF Health Science Center, UF Health Cancer Center, University of Florida, Gainesville, Florida 32610, United States.
Jun LiuDepartment of Medicinal Chemistry, College of Pharmacy, UF Health Science Center, UF Health Cancer Center, University of Florida, Gainesville, Florida 32610, United States.
Zixin ChenDepartment of Medicinal Chemistry, College of Pharmacy, UF Health Science Center, UF Health Cancer Center, University of Florida, Gainesville, Florida 32610, United States.ORCID 0000-0001-7441-1353
Zhishen WangDepartment of Medicinal Chemistry, College of Pharmacy, UF Health Science Center, UF Health Cancer Center, University of Florida, Gainesville, Florida 32610, United States.
Yuzhao ZhangDepartment of Medicinal Chemistry, College of Pharmacy, UF Health Science Center, UF Health Cancer Center, University of Florida, Gainesville, Florida 32610, United States.
Junxiang ZuoDepartment of Chemistry and Chemical Biology, University of New Mexico, Albuquerque, New Mexico 87131, United States.ORCID 0000-0002-2967-125X
Alberto Jimenez YbargollinDepartment of Medicinal Chemistry, College of Pharmacy, UF Health Science Center, UF Health Cancer Center, University of Florida, Gainesville, Florida 32610, United States.ORCID 0000-0001-7958-7761
Hua GuoDepartment of Chemistry and Chemical Biology, University of New Mexico, Albuquerque, New Mexico 87131, United States.ORCID 0000-0001-9901-053X
Lina CuiDepartment of Medicinal Chemistry, College of Pharmacy, UF Health Science Center, UF Health Cancer Center, University of Florida, Gainesville, Florida 32610, United States.ORCID 0000-0002-8149-5206
University of Florida Health · USUniversity of New Mexico · US

Funding

TR&D3-SCHP41GM122698 · NIGMS · FLORIDA STATE UNIVERSITY · PI BREY, WILLIAM W, CROSS, TIMOTHY A · 2017 to 2021
$6.7M
Probing the role of heparanase via in situ labelingR35GM124963 · NIGMS · UNIVERSITY OF NEW MEXICO · PI CUI, LINA · 2017 to 2021
$1.9M
Improved NMR Technology for Natural Products and Metabolomics.R01EB009772 · NIBIB · UNIVERSITY OF FLORIDA · PI EDISON, ARTHUR S · 2009 to 2012
$1.6M
NMR console upgrade for structural biology and metabolomicsS10OD028753 · OD · UNIVERSITY OF FLORIDA · PI LONG, JOANNA R · 2020 to 2020
$600k
Acquisition of a Q Exactive HF Hybrid Quadrupole-OrbitrapS10OD021758 · OD · UNIVERSITY OF FLORIDA · PI BASSO, KARI B · 2017 to 2017
$600k
NIBIB NIH HHS R01 EB009772NIGMS NIH HHS P41 GM122698NIGMS NIH HHS R35 GM124963NIH HHS S10 OD021758NIH HHS S10 OD028753
6 · The paper itself

Abstract

Heparanase (HPSE) is an endo-β-glucuronidase involved in extracellular matrix remodeling in rapidly healing tissues, most cancers and inflammation, and viral infection. Its importance as a therapeutic target warrants further study, but such is hampered by a lack of research tools. To expand the toolkits for probing HPSE enzymatic activity, we report the design of a substrate scaffold for HPSE comprised of a disaccharide substrate appended with a linker, capable of carrying cargo until being cleaved by HPSE. Here exemplified as a fluorogenic, coumarin-based imaging probe, this scaffold can potentially expand the availability of HPSE-responsive imaging or drug delivery tools using a variety of imaging moieties or other cargo. We show that electronic tuning of the scaffold provides a robust response to HPSE while simplifying the structural requirements of the attached cargo. Molecular docking and modeling suggest a productive probe/HPSE binding mode. These results further support the hypothesis that the reactivity of these HPSE-responsive probes is predominantly influenced by the electron density of the aglycone. This universal HPSE-activatable scaffold will greatly facilitate future development of HPSE-responsive probes and drugs.

Indexed as

Extracellular MatrixGlucuronidaseHeparanaseMolecular Docking SimulationPharmaceutical PreparationsGlucuronidaseHeparanasePharmaceutical Preparations

Identifiers

PMID36346913
PMCPMC10897860
OpenAlexW4308531497

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.